Nanologica
Manufactures nanoporous silica for cost-effective purification of peptide drugs for pharma.
NICA | ST
Overview
Corporate Details
- ISIN(s):
- SE0005454873 (+2 more)
- LEI:
- 54930017L41C7P87LP22
- Country:
- Sweden
- Address:
- Forskargatan 20 G, 151 36 Södertälje
- Website:
- https://nanologica.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Nanologica is a life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. The company specializes in nanoporous silica particles for preparative chromatography. Its flagship product, NLAB Saga®, is a high-performance silica medium engineered for the large-scale purification of peptide drugs, such as insulin and GLP-1 analogues used in treating diabetes and obesity. NLAB Saga® offers superior mechanical and chemical stability, which increases purification efficiency and product lifetime, thereby enhancing productivity and reducing costs for drug producers. The company's mission is to improve global access to cost-effective medicines through its advanced purification technologies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-23 08:10 |
Quarterly Report
|
Swedish | 732.3 KB | ||
| 2025-10-23 08:10 |
Quarterly Report
|
English | 736.5 KB | ||
| 2025-10-22 09:41 |
Regulatory News Service
Nanologica AB (publ) tar order om ca 1 MSEK i Kina
|
Swedish | 45.3 KB | ||
| 2025-10-22 09:41 |
Regulatory News Service
Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China
|
English | 45.4 KB | ||
| 2025-10-16 16:34 |
ISS
Nanologica AB (publ) tar kompletterande order om ca 2,7 MSEK från kund i USA
|
Swedish | 48.5 KB | ||
| 2025-10-16 16:34 |
Regulatory News Service
Nanologica AB (publ) Receives Additional Order of approx. SEK 2.7 Million from …
|
English | 48.2 KB | ||
| 2025-10-14 11:53 |
Board/Management Information
NANOLOGICA ANNOUNCES NOMINATION COMMITTEE FOR THE ANNUAL GENERAL MEETING 2026
|
English | 39.0 KB | ||
| 2025-10-14 11:53 |
Board/Management Information
NANOLOGICAS VALBEREDNING UTSEDD INFÖR ÅRSSTÄMMAN 2026
|
Swedish | 39.5 KB | ||
| 2025-10-01 09:55 |
Regulatory News Service
Nanologica AB (publ) Enters the Insulin Market in China
|
English | 47.5 KB | ||
| 2025-10-01 09:55 |
Regulatory News Service
Nanologica AB (publ) tar sig in på insulinmarknaden i Kina
|
Swedish | 47.7 KB | ||
| 2025-07-10 08:10 |
Quarterly Report
|
Swedish | 828.6 KB | ||
| 2025-07-10 08:10 |
Quarterly Report
|
English | 856.3 KB | ||
| 2025-06-30 11:00 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Nanologica AB (publ)
|
Swedish | 44.5 KB | ||
| 2025-06-30 11:00 |
Share Issue/Capital Change
Number of Shares and Votes in Nanologica AB (publ)
|
English | 43.9 KB | ||
| 2025-06-13 10:34 |
M&A Activity
UTTALANDE FRÅN STYRELSEN I NANOLOGICA AB (PUBL) MED ANLEDNING AV BUDPLIKTSERBJU…
|
Swedish | 51.9 KB |
Automate Your Workflow. Get a real-time feed of all Nanologica filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nanologica
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nanologica via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-25 | Thomas Eldered | Other | Buy | 666,570 | 661,170.78 SEK |
| 2024-10-03 | Mattias Bengtsson | Other | Other | 114,361 | 1,029,249.00 SEK |
| 2024-10-03 | Gisela Sitbon | Other | Other | 333,336 | 750,006.00 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 917,641 | 2,294,102.50 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 917,641 | 2,064,692.25 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 447,628 | 1,119,070.00 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 447,628 | 1,007,163.00 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 351,631 | 879,077.50 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 351,631 | 791,169.75 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 72,507 | 181,267.50 SEK |
Peer Companies
